Skip to search formSkip to main contentSkip to account menu

Patient Reported Outcomes Version of CTCAE

Known as: PRO-CTCAE, Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE) 
A library of items for patient self-reporting of symptoms and side effects associated with cancer treatment trials.(PRO-CTCAE)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Extramammary Paget's disease (EMPD) is a rare cutaneous adenocarcinoma generally arising in the anogenital region. Surgery is… 
2017
2017
PurposeTo assess the efficacy, safety, and outcome of image-guided high-dose-rate (HDR) brachytherapy in patients with adrenal… 
2015
2015
6004 Background: This is a prospective multi-institutional phase II study of a substantial decrease in chemoradiotherapy (CRT… 
2015
2015
benutzen. Die Dosis des vaginalen und nodalen Planungszielvolumen betrug 45 Gy in 25 Fraktionen. Um die Compliance mit den… 
Review
2014
Review
2014
64 Background: In a busy DC setting, the efficiency of identifying important treatment toxicities is essential to quality care… 
Review
2013
Review
2013
Background The US National Cancer Institute(NCI)-Common Terminology Criteria for Adverse Events(CTCAE)is a longstanding… 
2010
2010
9060 Background: A patient-reported outcomes (PRO) version of the NCI's Common Terminology Criteria for Adverse Events (CTCAE…